259 related articles for article (PubMed ID: 11432708)
21. Molecular alterations in atypical adenomatous hyperplasia occurring in benign and cancer-bearing lungs.
Gradowski JF; Mantha GS; Hunt JL; Dacic S
Diagn Mol Pathol; 2007 Jun; 16(2):87-90. PubMed ID: 17525677
[TBL] [Abstract][Full Text] [Related]
22. High resolution chromosome 3p allelotyping of human lung cancer and preneoplastic/preinvasive bronchial epithelium reveals multiple, discontinuous sites of 3p allele loss and three regions of frequent breakpoints.
Wistuba II; Behrens C; Virmani AK; Mele G; Milchgrub S; Girard L; Fondon JW; Garner HR; McKay B; Latif F; Lerman MI; Lam S; Gazdar AF; Minna JD
Cancer Res; 2000 Apr; 60(7):1949-60. PubMed ID: 10766185
[TBL] [Abstract][Full Text] [Related]
23. Somatic genetic changes in lung cancer and precancerous lesions.
Sundaresan V; Heppell-Parton A; Coleman N; Miozzo M; Sozzi G; Ball R; Cary N; Hasleton P; Fowler W; Rabbitts P
Ann Oncol; 1995; 6 Suppl 1():27-31; discussion 31-2. PubMed ID: 8695540
[TBL] [Abstract][Full Text] [Related]
24. Proliferative activity and loss of function of tumour suppressor genes as 'biomarkers' in diagnosis and prognosis of benign and preneoplastic oral lesions and oral squamous cell carcinoma.
Girod SC; Pfeiffer P; Ries J; Pape HD
Br J Oral Maxillofac Surg; 1998 Aug; 36(4):252-60. PubMed ID: 9762452
[TBL] [Abstract][Full Text] [Related]
25. Genetic alterations of multiple tumor suppressors and oncogenes in the carcinogenesis and progression of lung cancer.
Osada H; Takahashi T
Oncogene; 2002 Oct; 21(48):7421-34. PubMed ID: 12379883
[TBL] [Abstract][Full Text] [Related]
26. Genetic markers for early detection of lung cancer and outcome measures for response to chemoprevention.
Wiest JS; Franklin WA; Drabkin H; Gemmill R; Sidransky D; Anderson MW
J Cell Biochem Suppl; 1997; 28-29():64-73. PubMed ID: 9589350
[TBL] [Abstract][Full Text] [Related]
27. [Application of molecular diagnosis to human lung cancer].
Isobe T
Rinsho Byori; 1995 Aug; 43(8):792-8. PubMed ID: 7474438
[TBL] [Abstract][Full Text] [Related]
28. Molecular changes track recurrence and progression of bronchial precancerous lesions.
Sozzi G; Oggionni M; Alasio L; Conte D; Tavecchio L; Pilotti S; Spinelli P; Calarco G
Lung Cancer; 2002 Sep; 37(3):267-70. PubMed ID: 12234694
[TBL] [Abstract][Full Text] [Related]
29. Increased allelic loss in toluidine blue-positive oral premalignant lesions.
Epstein JB; Zhang L; Poh C; Nakamura H; Berean K; Rosin M
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2003 Jan; 95(1):45-50. PubMed ID: 12539026
[TBL] [Abstract][Full Text] [Related]
30. [Oncogenes and tumor suppressor genes in the pathogenesis of lung tumors].
Wiethege T; Voss B; Müller KM
Pathologe; 1994 Dec; 15(6):321-30. PubMed ID: 7855100
[TBL] [Abstract][Full Text] [Related]
31. Autofluorescence bronchoscopy, a novel modality for the early detection of bronchial premalignant and malignant lesions.
Hanibuchi M; Yano S; Nishioka Y; Miyoshi T; Kondo K; Uehara H; Sone S
J Med Invest; 2007 Aug; 54(3-4):261-6. PubMed ID: 17878675
[TBL] [Abstract][Full Text] [Related]
32. Molecular pathogenesis of lung cancer and potential translational applications.
Minna JD; Fong K; Zöchbauer-Müller S; Gazdar AF
Cancer J; 2002; 8 Suppl 1():S41-6. PubMed ID: 12075701
[TBL] [Abstract][Full Text] [Related]
33. [Molecular cell biology--basis for new diagnostic and therapeutic approaches in surgical oncology].
von Knebel Doeberitz M; von Knebel Doeberitz C
Chirurg; 1998 Apr; 69(4):339-48. PubMed ID: 9612615
[TBL] [Abstract][Full Text] [Related]
34. Molecular alterations in spontaneous sputum of cancer-free heavy smokers: results from a large screening program.
Baryshnikova E; Destro A; Infante MV; Cavuto S; Cariboni U; Alloisio M; Ceresoli GL; Lutman R; Brambilla G; Chiesa G; Ravasi G; Roncalli M
Clin Cancer Res; 2008 Mar; 14(6):1913-9. PubMed ID: 18347195
[TBL] [Abstract][Full Text] [Related]
35. Modulation of oncogene and tumor-suppressor gene expression: a novel strategy for cancer prevention and treatment.
Roth JA
Ann Surg Oncol; 1994 Jan; 1(1):79-86. PubMed ID: 7834433
[TBL] [Abstract][Full Text] [Related]
36. Molecular and cytogenetic alterations in early stage of carcinogenesis of human lung.
Cheng S; Gao Y; Dong X; Lu Y; An Q; Tong T; Wang Y
Cancer Lett; 2001 Jan; 162 Suppl():S5-S10. PubMed ID: 11164184
[TBL] [Abstract][Full Text] [Related]
37. A translational view of the molecular pathogenesis of lung cancer.
Sato M; Shames DS; Gazdar AF; Minna JD
J Thorac Oncol; 2007 Apr; 2(4):327-43. PubMed ID: 17409807
[TBL] [Abstract][Full Text] [Related]
38. Genome-wide allelotyping of lung cancer identifies new regions of allelic loss, differences between small cell lung cancer and non-small cell lung cancer, and loci clustering.
Girard L; Zöchbauer-Müller S; Virmani AK; Gazdar AF; Minna JD
Cancer Res; 2000 Sep; 60(17):4894-906. PubMed ID: 10987304
[TBL] [Abstract][Full Text] [Related]
39. Genetic alterations in head and neck squamous cell carcinomas.
Nagai MA
Braz J Med Biol Res; 1999 Jul; 32(7):897-904. PubMed ID: 10454750
[TBL] [Abstract][Full Text] [Related]
40. The biology of lung cancer including potential clinical applications.
Zöchbauer-Müller S; Minna JD
Chest Surg Clin N Am; 2000 Nov; 10(4):691-708. PubMed ID: 11091920
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
